Chinese Immuno-Oncology Company to Raise $282 Million Via Hong Kong IPO

CStone Pharmaceuticals is seeking to raise $282 Million in its upcoming Hong Kong IPO. The company's investors include Boyu Capital, Sequoia Capital, Oriza Holdings, and GIC.

The company raised $262 million in series B financing in 2018. Over 25% of the company's shares will be held by the public upon completion of the IPO.